Biomedicine will make France a healthcare leader, ministers say
The French government launched an ‘acceleration strategy’, backed by €800 million, for biotherapies—treatments that are produced by living systems, including both therapeutic antibodies and techniques relying on the patient’s own cells and tissue.
Frédérique Vidal, minister of higher education and research, Agnès Pannier-Runacher, minister delegate for industry, and Guillaume Boudy, France’s secretary general for investment, launched the strategy at an event on 7 January.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.